Montreal Toulouse Test With Eye Tracking in Intensive Care Unit to Evaluate Comprehension
MEXICO
Montreal Toulouse 86 Test Modified to be Used With Eye Tracking: Test Automation and Eye Course in Healthy Volunteers and Intensive Care Patients
1 other identifier
observational
113
1 country
1
Brief Summary
Assessment of the level of oral comprehension of the intensive care patient is essential to improve their care because they have often troubles like delirium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2020
CompletedFirst Submitted
Initial submission to the registry
June 23, 2021
CompletedFirst Posted
Study publicly available on registry
October 14, 2021
CompletedOctober 14, 2021
October 1, 2021
1.6 years
June 23, 2021
October 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Establish eye tracking standards for the test
fixation time measurement in the defined area of interest
during hospitalization in intensive care
Study Arms (2)
Healthy volunteers
healthy volunteers
intensive care patient
patient hospitalized in intensive care unit
Interventions
participant pass an eye tracking test to evaluate comprehension
Eligibility Criteria
Healthy volunteers and patient hospitalized in intensive care unit
You may qualify if:
- French speaker, RASS (Richmond Agitation-sedation scale) between -1 and +1, agree for participation
You may not qualify if:
- neurovisual disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Tours
Tours, 37000, France
Study Officials
- PRINCIPAL INVESTIGATOR
Laetitia BODET-CONTENTIN, MD-PhD
University Hospital of TOURS
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2021
First Posted
October 14, 2021
Study Start
March 7, 2019
Primary Completion
September 25, 2020
Study Completion
September 25, 2020
Last Updated
October 14, 2021
Record last verified: 2021-10